PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
165.94%
Net income growth above 1.5x CNQ's 47.22%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
13.17%
D&A growth well above CNQ's 11.53%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-98.43%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-132.14%
Both cut yoy SBC, with CNQ at -190.72%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
87.10%
Well above CNQ's 133.15% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
97.78%
AR growth of 97.78% while CNQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-121.43%
Negative yoy usage while CNQ is 133.15%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-228.57%
Negative yoy while CNQ is 62.61%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
3.25%
Operating cash flow growth below 50% of CNQ's 71.70%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
0.20%
Lower CapEx growth vs. CNQ's 10.06%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-22.73%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-100.00%
Negative yoy purchasing while CNQ stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
100.00%
Liquidation growth of 100.00% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
95.09%
We have some outflow growth while CNQ is negative at -4020.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-2.58%
Both yoy lines negative, with CNQ at -27.47%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-4.76%
Both yoy lines negative, with CNQ at -119.23%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.